Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sexton

Showing results (381-390 of 518) with videos related to

Pageof 52
Sort By:
Physical Chemistry Chemical Physics : PCCP|October 2, 2010
Characterization of C-H...π interactions in the structure of the CHClF(2)-HCCH weakly bound complexJohn M Sexton, Ashley A Elliott, Amanda L Steber, et al.
Molecular Pharmacology|June 16, 2010
Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screeningCassandra Koole, Denise Wootten, John Simms, et al.
Bone|July 28, 1999
Calcitonin receptor antibodies in the identification of osteoclastsJ M Quinn, M Morfis, M H Lam, et al.
The Biochemical Journal|January 1, 1991
Reversible calcitonin binding to solubilized sheep brain binding sitesP M Sexton, H G Schneider, C S D'Santos, et al.
Cell|February 25, 2017
Structure of the Adenosine A<sub>1</sub> Receptor Reveals the Basis for Subtype SelectivityAlisa Glukhova, David M Thal, Anh T Nguyen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1987
Calcitonin receptors of human osteoclastomaG C Nicholson, M A Horton, P M Sexton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2014
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonistCeline Valant, Lauren T May, Luigi Aurelio, et al.
Urology|May 18, 2022
Favorable Outcomes With Early Component Separation, Primary Closure of Necrotizing Soft Tissue Infections of the Genitalia (Fournier's Gangrene) Debridement Wound DefectsJason M Sandberg, Hayden L Warner, Kevin J Flynn, et al.
Biochemical and Biophysical Research Communications|September 21, 2021
Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptorRachel M Johnson, Xin Zhang, Sarah J Piper, et al.
Molecular Pharmacology|October 17, 2014
Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of bindingMaoqing Dong, Ashton M Vattelana, Polo C-H Lam, et al.
Pageof 52

Showing results (381-390 of 518) with videos related to

Sort By:
Pageof 52
Physical Chemistry Chemical Physics : PCCP|October 2, 2010
Characterization of C-H...π interactions in the structure of the CHClF(2)-HCCH weakly bound complexJohn M Sexton, Ashley A Elliott, Amanda L Steber, et al.
Molecular Pharmacology|June 16, 2010
Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screeningCassandra Koole, Denise Wootten, John Simms, et al.
Bone|July 28, 1999
Calcitonin receptor antibodies in the identification of osteoclastsJ M Quinn, M Morfis, M H Lam, et al.
The Biochemical Journal|January 1, 1991
Reversible calcitonin binding to solubilized sheep brain binding sitesP M Sexton, H G Schneider, C S D'Santos, et al.
Cell|February 25, 2017
Structure of the Adenosine A<sub>1</sub> Receptor Reveals the Basis for Subtype SelectivityAlisa Glukhova, David M Thal, Anh T Nguyen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1987
Calcitonin receptors of human osteoclastomaG C Nicholson, M A Horton, P M Sexton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2014
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonistCeline Valant, Lauren T May, Luigi Aurelio, et al.
Urology|May 18, 2022
Favorable Outcomes With Early Component Separation, Primary Closure of Necrotizing Soft Tissue Infections of the Genitalia (Fournier's Gangrene) Debridement Wound DefectsJason M Sandberg, Hayden L Warner, Kevin J Flynn, et al.
Biochemical and Biophysical Research Communications|September 21, 2021
Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptorRachel M Johnson, Xin Zhang, Sarah J Piper, et al.
Molecular Pharmacology|October 17, 2014
Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of bindingMaoqing Dong, Ashton M Vattelana, Polo C-H Lam, et al.
Pageof 52